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CBackground: Worldwide, there is a need for formalization of the pri-
ority setting processes in health. Recent research has used the term
multicriteria decision analysis formethods that systematically include
preferences for both equity and efficiency. The present study compares
decision-makers’ preferences at the country level for a set of equity and
efficiency criteria according to a multicriteria decision analysis
framework. Methods: Discrete choice experiments were conducted
or Brazil, Cuba, Nepal, Norway, and Uganda. By using standardized
ethods, we elicited preferences for intervention attributes using a
ndividual choice questionnaire. Amultinomial logistic regression was
pplied to estimate the coefficients for all single-policy criteria, per
ountry. Attributes were assigned to an equity group or to an efficiency
roup. After testing for scale variance, predicted probabilities for inter-
entionswith both types of attributeswere compared across countries.
esults: The Norway and Nepal groups showed considerable prefer- O
oom
al So
ttp://dx.doi.org/10.1016/j.jval.2012.04.001nces for efficiency criteria over equity criteria with percent change in
espective predicted sum probabilities of [10%, 84%] and [6%, 79%].
razil and Uganda also showed preference for the efficiency criteria
hough less convincingly ([34%, 93%], [18%, 63%], respectively).
he Cuban group showed the strongest preferences with equity attri-
utes dominating efficiency ([52%, 213%]). Conclusions: Group pref-
rences of policymakers show explicit but varying trade-offs of effi-
iency and equity in these diverse settings. This multicriteria decision
nalysis approach, using discrete choice experiments, indicates that
ystematic setting of health priorities is possible across a variety of
ountries. It may be a valuable tool to guide health reform initiatives.
eywords: discrete choice experiment, efficiency, equity, priority set-
ing.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Worldwide, there is a need for formalization of health priority
setting processes at both the national and local levels [1–5]. Too
ften policy decisions aremadewithout transparency of decision-
aking criteria, but with implicit trade-offs. Some countries have
aken steps toward making the process more transparent such as
n the United Kingdomwhere the coalition government’s program
n “Freedom, Fairness and Responsibility” reconfirmed the lead-
ng role of the National Institute for Health and Clinical Excellence
NICE) to support value-based decisions in health care [6]. With its
5-year-old advanced health priority setting system, which takes
n efficiency-based, extra-welfarist approach, the United King-
om is currently reviewing its threshold cost per quality-adjusted
ife-year as a reference base for health funding decisions. In low-
* Address correspondence to: Andrew Mirelman, Johns Hopkins Bl
altimore, MD 21205, USA.
E-mail: amirelma@jhsph.edu.
098-3015/$36.00 – see front matter Copyright © 2012, Internation
ublished by Elsevier Inc.and middle-income countries, the decision-making criteria are
less formalized. With the adoption of the Millennium Develop-
ment Goals, developing country governments havemade commit-
ments to address major health issues affecting their populaces, in
areas of maternal health, child health, and HIV/AIDS. While these
goals have been implemented into the health plans of the minis-
tries of health in many developing countries, progress on the Mil-
lennium Development Goals has been slow. Making national and
local decision-making criteria and values more transparent may
be part of a solution toward achieving better health outcomes in
an effective manner.
Preference-based techniques provide a tool for mapping the
policy environment and have a potential to lead to evidence-based
development of policies. Methodologies such as cost-effective
analysis have been increasingly used to provide evidence for
smarter policy decisions. While cost-effective analysis has been
berg School of Public Health, 615 North Wolfe Street, Room E8132,
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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535V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 5 3 4 – 5 3 9useful in the past decade in institutions such as NICE, this meth-
odology carries limitations [7–11]. While the concept of efficiency
is incorporated into cost-effective analyses, it does not inherently
capture a clinical perspective, such as severity of the disease nor
the societal distribution of disease and disability from the policy
perspective [7–9]. National agencies, such as NICE, have stated
hat the formal inclusion of social values in the national policy
rocess may be applied as a result of local interpretation of rec-
mmendations, which could lead to variations in regional and
istrict health service delivery [10,11].
In the past decade, systematic techniques have been devel-
ped to define the rational basis of allocating health services. This
ork has coalesced into a subfield of health economics with pref-
rence research presenting themethods and feasibility for includ-
ng equity, efficiency, and other criteria in decision making in a
ariety of countries and settings [1–3,11–17]. These experiences
ay show a substantial and important impact of these criteria on
ecision making based on effectiveness and efficiency [12].
The analysis presented here explores what attributes a di-
ersity of national-level policymakers in five countries find im-
ortant while formulating plans on the extension and distribu-
ion of health care services in environments with constrained
esources. We apply a method to analyze the simultaneous use
f several criteria based on discrete choice experiments (DCEs)
pplied in health [14,18,19]. The use of DCEs fits into a broader
ramework for using evidence for rational priority setting,
hich is termed multicriteria decision analysis (MCDA)
12,15,20–25]). MCDA findings can illuminate similarities and
ifferences across groups of country decision makers for a more
ransparent policy process.
The objective of our present studywas to describe the decision-
aking process used by policymakers applying DCEs conducted in
ultiple country settings using an MCDA framework and present
comparative analysis of the results across countries. In doing so,
e group the criteria results in an equity and efficiency category to
stimate the relative importance of these two criteria in country
ealth priority settings.
A Diversity of Country Health Systems
Our sample of five countries explicitly accounts for the diversity in
economic development, population size, and state of health care
systems across the globe. Countries were selected in whichMCDA
had been performed by using similar questionnaire designs.
Among their national health systems, the countries exhibit much
heterogeneity and different levels of sophistication. The countries
also vary by the level of gross domestic product (GDP) per capita
ranging from very low-income countries such as Uganda and
Nepal to the middle-income country Brazil and the high-income
country Norway. A brief overview of each country’s health system
characteristics is provided here.
Nepal is at the lowest end of the scale for GDP and has a na-
tional public health service. The country has taken many steps to
address the Millennium Development Goals, and the governmen-
tal health sector develops both short-term and long-term strategic
plans for the improvement of health indicators. The most recent
long-term health plan for 1997–2017 explicitly focuses on provid-
ing care to its marginalized populations. Uganda receives a large
amount of donor support for its health system including substan-
tial funding from the United States’ President’s Emergency Plan
for AIDS Relief program. Classified as a low-income country by the
World Bank, Uganda is confronted with high levels of HIV/AIDS
and malaria. Despite its significant health problems, under five
mortality rates and maternal mortality rates have been steadily
declining in Uganda for the past few years. A coordinated effort for
health provision in Uganda occurs through the national Health
Sector Strategic Planning initiative that involves hospitals, district
health centers, and village health teams. While the governmentand donors provide many essential health services, Uganda is re-
liant on out-of-pocket payments and private insurance companies
to pay for services.
Cuba’s national health system is managed by the Cuban gov-
ernment, which assumes fiscal and administrative responsibility
for the funding and delivery of health care to all its citizens. While
one may expect stakeholders in health in Cuba to have a prefer-
ence for equitable distribution of health programs, Cuba also pur-
sues efficiency through one of themost proactivemedical training
programs in the world. In Brazil, the provision of health care fol-
lows multiyear plans developed through the country’s Unified
Health System. These 4-year plans focus on issues such as reduc-
ing child mortality, political organization of the health sector, and
consolidation of decentralization of the health care system. The
government focuses on primary care provision through the Family
Health Program, through collaboration between the national Min-
istry of Health and individual states. The private sector comprises
the majority of the overall services provided in terms of expendi-
tures.
Norway, at the highest end of the GDP scale, has a health sys-
tem that is completely centralized. The entire population is cov-
ered by the national health plan, and it has a well-established
financing and service provision system. As with other developed
countries, Norway faces a growing issue of how to tailor its health
system to a population that is quickly aging.
Methods
We used a standardized survey with a core set of preference cri-
teria as attributes based on literature reviews and verified by na-
tional focus groups before each DCE took place (12,17,26]. Our
study identified six primary attributes for the present analysis,
which include key criteria used in health decisions. Five attributes
each had two levels and one attribute, the age criteria, had three
levels. The attributes were disease severity (healthy life expec-
tancy less than 2 years), total beneficiaries (reaching more than
10% of the population), age (reaching groups in low, middle, and
upper ages), individual benefits (giving greater than 5 years of full
health), willingness to subsidize (propoor, greater than 70% gov-
ernment subsidization), and cost-effective (cost per life-year less
than gross national product per capita). These attributes are con-
sistent with those used in previous studies, which have been
shown to be important criteria for understanding the preferences
when choices are made for prioritizing interventions [1,12]. The
parameter definitions remained consistent for all five countries.
Nepal data were collected by using slight variations in definitions
for the variables, which were modified to allow for an analysis
with the other countries. All attribute definitions are detailed in
Appendix A as Supplemental Materials found at doi 10.1016/j.
jval.2012.04.001. The research group selected the five countries
(Cuba, Brazil, Uganda, Norway, and Nepal) included in this study
(L.N. and F.P.), allowing for a large range of health systems and
development stages as indicated by GDP and coverage level of the
national health system.We follow standardizedDCEmethodology
and have reported individual country studies elsewhere (for a
summary, see Baltussen et al. [1]). Table 1 provides a summary of
the country respondents and settings including the number of
participants and the response rate.
The data collection methodology was standardized across
countries. Preparatoryworkshops and direct self-administered in-
terviews were carried out together with leading local country re-
searchers and organizers from established research institutions.
There were up to 80 policymakers per country who participated in
this study. A core group for each country was involved in the ad-
aptation and translation of the DCE questionnaire, supervised the
implementation of the survey, and chaired the survey and feed-
back sessions. Respondents took on average 1 hour to complete
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536 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 5 3 4 – 5 3 9the questionnaire. All surveys were conducted in person accord-
ing to protocol. Table 1 provides a summary of the country respon-
dents and settings including the number of participants and the
response rate. The response rate was high, ranging between 91%
and 100% across countries. In each case, the choice experiment
was carried out inside each country among groups of relevant
policymakers and decision makers involved in national-level de-
cisions. Individuals from countries outside of the sample or with
international positions were not included. The specific attributes
as described in the Appendix were included in a protocolized ex-
perimental design with a high efficiency (99.4%) [1,17,26,27]. To
facilitate the consistency of answers, participants in the surveys
were further given instructions and coaching on how to answer
the questionnaires correctly, both in the group sessions and indi-
vidually. Collected data were pooled for all countries, and a pa-
rameterized heteroskedasticmultinomial logitmodelwas fitted to
test for the equality of scale (i.e., variance) across countries [28,29].
ubsequently, we tested for the equality of the estimated param-
ters between models by using a likelihood ratio test [29–31].
To make inferences, we employed the percentage differences
Table 2 – Model (heteroskedastic MNL) results for six polic
All Brazil
Disease severity 0.468‡ (0.000) 0.501‡ (0.000
Total beneficiaries 0.354‡ (0.000) 0.660‡ (0.000
Target age mid 0.0705 (0.249) 0.386‡ (0.001
Target age high 0.453‡ (0.000) 0.0928 (0.342
Individual benefits 0.451‡(0.000) 0.507‡ (0.000
Propoor (WTS) 0.162‡ (0.000) 0.0101 (0.926
Cost-effectiveness 0.871‡ (0.000) 1.498‡ (0.000
Scale
Brazil 0.158 (0.211)
Cuba 15.26 (0.977)
Uganda 0.235 (0.184)
Norway 0.126 (0.309)
Chi-square test equality of scales 5.34 (0.255)
Log-L 2047.7 484.6
LR test equality of parameters 357.3 (0.000)
No. of observations 7178 2126
No. of individuals 225 73
Note. P values in parentheses. LR test calculated as 2[LLPooled – (LLB
LR, likelihood ratio; MNL, multinomial logit; WTS, willingness to sub
* P  0.1.
† P  0.05.
Table 1 – Characteristic country respondents.
Brazil Cuba
Number 73 37
Respondent type in
health field
Policymakers
and
professionals
Policymakers and
professionals
Poli
ex
Sampling frame National level National level Nat
le
Experience (y) Junior to senior Junior to senior Sen
Response rate (%) 91 97
Setting Center for Health
Economics,
São Paulo
Cuban Society for
Health
Economics,
Havana
Uga
of
Note. Professionals: researchers ormedical experts; health experts: m‡ P  0.01.n predicted probabilities [32]. Differences in predicted probabili-
ies take into account the problemswith varying levels of the scale
ttributes and allow comparisons of the five countries [33]. The
ase scenario (from which differences are calculated) is an option
here all attributes take the value of 1 (except for agewhere upper
ge is 1) while the other alternatives simulate the effects of select-
ng interventions based on equity and efficiency.
The attributes were post hoc categorized as belonging to either
he equity or efficiency realm. The equity category includes crite-
ia for fairness, defined as any criterion dealing with the distribu-
ional impact across subpopulations such as age, income level,
nd severity of disease [12,34]. The category of efficiency, defined
s themaximal health gain for the least cost, included attributes of
ndividual health impact, health impact by total number of people,
nd health impact per cost. Attributes classified for equity were
isease severity, age group, and willingness to subsidize, while
hose classified for efficiency were total beneficiaries, individual
enefit, and cost-effectiveness.
By using these common definitions for equity and efficiency,
e introduced three hypothetical interventions: one baseline in-
eria, by country.
Cuba Uganda Norway Nepal
0.158 (0.153) 0.698‡ (0.000) 0.682‡ (0.000) 0.538‡ (0.000)
1.032‡ (0.000) 0.355† (0.012) 0.238† (0.028) 0.484‡ (0.000)
0.810‡ (0.000) 0.137 (0.408) 0.243 (0.133) 0.358‡ (0.002)
0.284* (0.051) 0.719† (0.026) 0.978‡ (0.000) 0.833‡ (0.000)
0.258‡ (0.002) 0.200 (0.222) 0.688‡ (0.001) 0.579‡ (0.000)
0.604‡ (0.000) 0.221 (0.247) 0.203 (0.110) 0.235‡ (0.001)
0.150* (0.067) 0.444‡ (0.002) 0.936‡ (0.000) 0.510‡ (0.000)
346.7 148.9 270.9 617.9
1144 518 1024 2366
37 17 32 66
LLCuba  LLUganda  LLNorway  LLNepal)].
.
Uganda Norway Nepal
17 32 66
kers and health Policymakers and
professionals
Policymakers and
health experts
and program National level National and program
level
Mid-level to senior Mid-level
95 100 100
ational Academy
nces, Kampala
Directorate of Health
and Public Health
Offices, Oslo
Directorate of Health,
Kathmandu
l or public health experts; time period: Nepal 2006; others 2009–2010.y crit
)
) 
)
)
) 
)
)
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sidizecyma
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537V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 5 3 4 – 5 3 9tervention (with all attributes equal to 1), a second with all attri-
butes for efficiency equal to 1 (and all equity attributes equal to 0),
and a third intervention with all equity attributes equal to 1 (and
all efficiency attributes equal to 0). These three interventions
(baseline, efficiency, and equity) are shown in Table 3 as S0, S1,
nd S2.
By applying these reference interventions, we calculated the
redicted probability of selection for the baseline intervention and
hen for the subsequent interventions with qualities of either eq-
ity or efficiency. The difference between the predicted probabil-
ties for the equity-only and efficiency-only interventions and that
f the baseline intervention is taken by simple subtraction and
hen the percentage change is calculated with respect to the base-
ine predicted probability. Using this approach, the magnitude of
he contribution of the equity and efficiency components is as-
essed, indicating the implicit willingness to trade-off equity and
fficiency. To ease the interpretation of this trade-off, we present
n equity-efficiency frontier by plotting the extreme values {1,0}
nd {0,1}, and fit a logarithmic curve for the frontier [35].
Results
On the basis of the heteroskedastic multinomial logit and the sub-
sequent likelihood ratio test, we find that variance scale is not a
problem in the sample of countries, and we can safely ignore its
effects. The results for one country—China—did not pass this test
and were excluded from the comparison. Table 2 presents the
estimation results by country. The results show that preferences
appeared relatively consistent across the diversity of country
health systems. Significant decision-making criteria (at P 0.05 or
below) in Brazil were disease severity, total beneficiaries, middle
age group, individual benefits, and cost-effectiveness. Cuba se-
lected criteria for total beneficiaries, middle age group, individual
benefit, and willingness to subsidize as important. Uganda
showed significant preferences for disease severity, total benefi-
ciaries, upper age group, and cost-effectiveness. All criteria except
middle age group and willingness to subsidize were significant in
Norway, while all criteria weights were significant in Nepal.
Some notable findings are the large positive preferences for
Table 3 – Country equity and efficiency preference results.
Intervention Log odds of selection
Brazil
Base S0 3.08
Equity S1 0.42
Efficiency S2 2.67
Cuba
Base S0 0.41
Equity S1 0.73
Efficiency S2 1.14
Uganda
Base S0 1.20
Equity S1 0.20
Efficiency S2 1.00
Norway
Base S0 1.77
Equity S1 0.09
Efficiency S2 1.86
Nepal
Base S0 1.517
Equity S1 0.06
Efficiency S2 1.57cost-effective interventions in Brazil and Norway, which contrib-ute to the preference for efficiency in these countries. Cuba
showed large positive preferences for the middle age group and
willingness to subsidize and negative preferences for total benefi-
ciaries and individual benefit, all contributing to the preference for
equity. Nepal gave positive weights for all factors except for the
upper age group criterion, which was negative. The most impor-
tant criteria preferences that this group prefers were disease se-
verity and individual health gains. By the nature of the scaling
method, one cannot directly compare the country results in Table
2 across countries; however, we canmake conclusions on the pref-
erences for equity compared with efficiency within each country.
Table 3 shows the predicted probabilities by country when
comparing baseline probability values with the equity-only and
efficiency-only interventions and the percentage differences. The
absolute differences are depicted in Figure 1 and give themarginal
preference levels for interventions with either all-equity or all-
efficiency criteria compared with the baseline. This figure shows
that Cuba exhibits a highly positive preference for equity and is
ready to give up on efficiency when doing so, as shown by the
placement in the southeast quadrant of Figure 1. Among the other
countries, Norway shows a trade-off for efficiency over equity,
shown by the placement in the northwest quadrant. Brazil, Nepal,
Fig. 1 – Country differences in probability of selection for
bability of selection Percentage difference of predicted
probabilities (in reference to the
base intervention) (%)
0.56
0.04 93
0.37 34
0.16
0.51 213
0.08 52
0.40
0.15 63
0.33 18
0.41
0.06 84
0.45 10
0.40
0.08 79
0.43 6Prointerventions of efficiency and equity.
538 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 5 3 4 – 5 3 9and Uganda all show that the baseline intervention is the most
preferred, being placed in the southwest quadrant; however, the
small distances from the efficiency axis for all three countries
means that efficiency is only slightly preferred over equity.
In Figure 2, the equity and efficiency probabilities of selection
from Table 3 were mapped onto an equity-efficiency frontier [35].
The country scores show that all the countries exhibit stronger
preferences for efficiency over equity, except for Cuba, where the
opposite is true. This is visualized by noting that all the countries
except Cuba are located above the 45° line, where the line repre-
sents an indifferent preference between equity and efficiency. The
curve shows the maximum levels of equity and efficiency that are
achievable given the measured preferences for each country
group.
Discussion
Four of the five countries that we studied demonstrated a prefer-
ence for efficiency over equity. While there can be many reasons
for this, it likely relates to the characteristics, in particular the
attitudes, of the included groups of policymakers and how they
perceived existing levels of efficiency and equity within their ex-
isting national health systems. Our results suggest that in addition
to the efficiency criteria examined here, further criteria of fairness
seem to play an additional but varying role in health decisions in
these countries.
The past 10 years have shown methodological progress in ad-
dressing these trade-offs in specific policy decisions as exempli-
fied by the role of NICE in the United Kingdom [11,18]. Ongoing
debates are taking place on the relative balance between fairness
and equity, as we reported for Norway [36]. Up to this point, the
importance of achieving efficiency at the national level often over-
rides concerns for equity and other policy imperatives at the re-
gional and local levels. Our study presents insights into theminds
of a diversity of decision makers, presented to formalize the
weighing of criteria in a deliberation process. Further studies of
other countries are required to expand the data set and to analyze
it in terms of income, relevant socioeconomic characteristics, and
geography. As future work is conducted, we recommend that de-
cision-making prioritization approaches present a balance be-
tween equity and efficiency. Balancing on these two characteris-
tics, as we have done, would ensure that an optimal level of equity
and efficiency is achieved when making decisions related to
health provision.
The limitations of our methodology come primarily from the
aggregation of individual country scores and the inevitably limited
sample of countries. These stem from conducting choice experi-
Fig. 2 – Efficiency-equity country frontier of maximum sum
scores on efficiency (y-axis) and equity (x-axis).ments in a uniform manner between countries, which may havevarying interpretations of attribute definitions. There are natu-
rally going to be variations in the time, space, and procedure for
conducting this experiment in diverse settings that limit the abil-
ity to draw robust generalizable comparisons. This is inherent to
the nature of this type of study and limits the direct comparability
of the results between countries. There is also evidence that sug-
gests that health decisions may take into account more factors
beyond equity and efficiency [26,36]. Our study focuses on criteria
classified into either equity or efficiency; however, if other opera-
tional factors influence decision making in a significant manner,
then our model will be underspecified. Future work should build
on our approach and measure preferences for other system-level
characteristics that may be identified as important to decision
makers [17,26,37]. Another limitation may be that our method-
ological approach used a post hoc classification of attributes and
changes in the predicted probabilities of simulated interventions
to account for heterogeneity in the data. In future work, explicit
concepts of equity and efficiency can be directly calibrated among
the interview participants at the beginning of the study to ensure
congruence of definitions and alternative preference elicitation
methods such as best-worst scaling method, which can address
scaling problems of both the variance and the levels, should be
attempted [38].
Given our consistent findings across the national groups of
policymakers and their face validity, one could argue in favor of
a more explicit use of MCDA in policymaking, while aiming at a
more transparent process. This may also be the case for older
nationalized health systems such as the United Kingdom, espe-
cially at local commissioning levels, where decisions are taken
with regard to multiple criteria and where MCDA is now under
wider consideration at a national level [11]. When a country
decides to design packages for health interventions or to eval-
uate health system efforts in terms of equity and efficiency, an
MCDA may be a valuable tool within the formal context of a
deliberative process. Explicitly stated preferences may assist
stakeholders at all levels to make difficult decisions by consid-
ering various trade-offs. DCE results provide an insightful point
for further studying and formalizing the rationales of decision
makers and, in addition, may contribute to further development
of a rational policy process.
Our results confirm that there are measurable preference dif-
ferences in relation to equity and efficiency criteria across coun-
tries. While this may seem like an obvious result, it is worth ex-
ploring where commonalities and differences exist. Many global
health initiatives operate across the globe in support of countries
that cannot yet support their own health systems and may apply
the same assumptions and processes across countries. Better un-
derstanding of local preferences with respect to equity and effi-
ciency may improve the acceptability and performance of inter-
national health programs. Monitoring these preferences over
time, perhaps at 5- to 10-year intervals, may also help reflect the
relationships between health, economic growth, and preferences.
Although this will vary to some degree, those with leading roles
in the political system in place in a certain time period will
moderate the outcomes; the explicit approach may provide
greater clarity on the stability and validity of these preferences.
Greater use of MCDA in health priority setting would likely
make national decisions more transparent and perhaps more
rational and allow countries to characterize their efficiency and
equity trade-offs in a manner that is consistent with their level
of development and societal preferences.
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